Blood Testing Market Boosted By Pricing Locks in Molecular Testing: Finds New Kalorama Report Driven by the use of molecular tests and inelastic pricing for them, the blood testing market is expected to grow in double-digits according to Kalorama Information. The healthcare market research publisher said the need to provide the lowest level of blood contaminants is driving sales of newer nucleic acid tests that are replacing immunoassay units. (PRWeb June 11, 2013) Read the full story at ...
June 11, 2013 - PRWeb